Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

coramaze technologies GmbH, a medical device company, develops a minimally invasive valve repair system for people with heart diseases. The company develops mitramaze valve repair system, a catheter-based valve that can be implanted directly into the beating heart and targets inoperable and asymptomatic patients. coramaze technologies GmbH was founded in 2013 and is based in Essen, Germany.

FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians. Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

Cairdac is a medtech startup that is creating on a self-sustaining leadless pacing system that uses an inertial energy harvester. The company used its assets and resources to become the first company in the world to successfully develop a self-sustaining pacemaker with a lifespan of more than 15 years. The use of a proprietary piezoelectric energy harvester in conjunction with its miniaturized ASIC "high-efficient power management circuit" enabled this energy performance. ALPSTM is a one-of-a-kind, autonomous, and endoscopically implanted leadless pacemaker with patented self-sustaining power technology that harvests the heart's kinetic energy. CAIRDAC applies disruptive technologies to traditional leadless pacemakers, meeting the growing needs of patients and healthcare professionals with an all-in-one, cost-effective solution that will revolutionize patients' quality of life.

CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

4tech AS provides tank gauging and surveillance systems. The company was founded in 1996 and is headquartered in Lier, Norway.

Cardiosolutions, Inc. develops and manufactures medical devices. It focuses on a novel percutaneous alternative to open heart surgery to solve the problem of mitral regurgitation. The firm offers Dexterity Steerable Introducer, a multi-use tool that enables physicians to access regions of the cardiac anatomy, which are difficult to reach, including the left side of the heart; and Percu – Pro System for reducing the degree of mitral regurgitation in patients with either functional or degenerative valve disease. The company was founded by Steven J. Tallarida in 2006 and is headquartered in West Bridgewater, MA.

MVRx is a medical device company that introduces ARTO System, a transcatheter annular reduction therapy. The ARTO System is a unique endovascular therapy for mitral valve regurgitation associated with congestive heart failure. The system treats heart failure by reducing the backward leakage of blood through the mitral valve thereby increasing the forward flow of blood to the rest of the body. ARTO directly reshapes the mitral annulus and improves leaflet coaptation by shortening the minor axis of the mitral valve through inward displacement of the septal and lateral walls. This reestablishes normal anatomic relationships and decreases regurgitation.

Part of BIOTRONIK SE & Co. KG, Biotronik AG is a Swiss company located in Bulach that manufactures devices for vascular intervention and electrotherapy of heart.\nThe company says this about itself: BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.

MiCardia is a privately held medical device company currently preparing for the commercialization of its first series of products, enCor™, in the European Union. enCor is a unique device that surgically treats mitral valve regurgitation. enCor utilizes the company's patented technology, Dynaplasty™, to provide a "second chance" to the patient who develops recurrent regurgitation. enCor can be activated to physiologically adjust the mitral valve leaflets to resolve regurgitation, minimally invasively, weeks to years later, without the need for the risk and cost of redo surgery.

Beijing Carditech Medical Equipment Technology Co., Ltd., established on 2018-06-12, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Import and export,Technology Import and Export;Sales of medical devicesIkind,IIkind;Production of Class I Medical Devices;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class II Medical Devices;Production of Class III Medical Devices,The operation of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Harmony Development Group is a heart-focused MedTech company. It works within the ventricle, functioning as an integrated systolic assist system that leverages the native energy of the heart. Their therapies work by aiding and supporting the diseased ventricle, restoring its natural shape, pressure, and flow.

Vectorious Medical Technologies developed the V-LAP, the worlds first in-heart microcomputer which enables optimal treatment for heart failure patients, increasing their quality of life and life expectancy. The V-LAP sensory implant is the first digital, wireless, battery-less device that is able to communicate from deep within the body. It monitors the heart’s left atrium pressure (LAP) which has been proven to be the earliest, most accurate and effective predictor for heart failure deterioration. Vectorious is actively conducting clinical studies in Europe (Italy, Germany, UK and Israel) for the purpose of obtaining a CE mark. It is expected to launch a clinical study in the US in 2020.

Sorin CRM SAS designs and manufactures implantable pacemakers and defibrillators. It offers ICDs, leads, holter equipment, and electrophysiology catheters. The company was founded on July 25, 1977 and is headquartered in Clamart, France.

EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. Its WiCS Wireless Cardiac Stimulation technology helps address the significant opportunity to eliminate cardiac pacing leads. The company was founded by Richard E. Riley and Debra Sheryl Echt in 2003 and is headquartered in Sunnyvale, CA.

Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

Suzhou Huihe Medical Technology Co., Ltd., established on 2019-12-25, The scope of business includes engaging in medical technology,Biotechnology,computer software,Internet technology,Technology development in the field of computer science and technology,technology transfer,technical consulting;medical instruments,electronic product,Instrumentation,Green facilities,Daily necessities,sales of cosmetics;Installation of general mechanical equipment,repair;Undertake computer network engineering;computer software development;Exhibition display service;General machinery and equipment rental;Business Consulting;Business Management Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Pacesetter, Inc., a subsidiary of Abbott Laboratories, is a company headquartered in the United States that manufactures, and distributes cardiovascular and implantable neuro stimulation medical devices.